Please login to the form below

Not currently logged in
Email:
Password:

Nexavar fails late-stage breast cancer trial

Bayer Nexavar sorafenib

Bayer’s oncology drug unable to improve progression free survival in new indication

GSK seeks approval for first malaria vaccine

dengue fever mosquitoSubmits marketing application to European Medicines Agency

FDA approves pain drug that has reduced risk of abuse

purdue pharma logoPurdue’s Targiniq ER developed to deter snorting and injection

Neupogen will be first biologic on FDA biosimilars pathway

FDA headquarters White OakUS regulator will review Novartis’ version of Amgen's Neupogen (filgrastim) over the coming months

Turkey aims to become ‘global player’ in biopharma

Turkey flagGovernment pledges to boost country’s support for medicines access and R&D

FDA approves Gilead drug in three blood cancers

FDA headquarters White OakZydelig recommended for use in chronic lymphocytic leukaemia and two forms of lymphoma

BMJ accuses Boehringer of withholding Pradaxa data

Boehringer Ingelheim Pradaxa dabigatran packClaims current FDA recommendation for anticoagulant may be flawed

Community pharmacies central to diabetes fight in UK

diabetes uk boots risk assessmentRisk assessments can help identify people at risk of developing condition

Boehringer goes on PR offensive over Pradaxa report

boehringer pradaxa twitterTakes to social media to defend its position on the anticoagulant ahead of tonight's Channel 4 news report

Managing pharma's uncertainty

Futures we can’t predict need a strategy we can’t plan

Latest appointments

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hall & Partners

We are a specialist brand and communications research consultancy offering you fresh ideas at every stage of the brand planning...

Latest intelligence

Online Physician Communities
M3 improves personalisation of pharma engagement with doctors
Launches new messaging service on Doctors.net.uk...
Digital Futures 2014 slide deck
Full slides, including survey data, from PMLiVE's digital pharma marketing online event...
The Chinese diabetes challenge
Marketing, communications and commercial relationships in China are full of pitfalls for the unwary, but not without great potential ...